Stimcell Energetics (STME) Net Margin (2016 - 2023)
Stimcell Energetics' (STME) quarterly Net Margin came in at 107274.32% in Q2 2023, down 9357921.0% year-on-year from N/an in Q2 2022, and down 101.55% quarter-over-quarter from 53225.68% in Q1 2023.
Stimcell Energetics (STME) Net Margin (2016 - 2023) Analysis & Trends
Stimcell Energetics' Net Margin history runs 7 years deep, the most recent figure standing at 107274.32% for Q2 2023.
- On a quarterly basis, Net Margin fell 9357921.0% year-over-year to 107274.32% in Q2 2023; TTM through Feb 2024 was 384363.51%, a 36323746.0% decrease from a year earlier, with the FY2023 full-year figure at 83622.66%, up 1917134.0% from the prior year.
- Net Margin retreated to 107274.32% in Q2 2023 per STME's latest filing, from 53225.68% in the prior quarter.
- Across five years, Net Margin topped out at 330.53% in Q2 2020 and bottomed at 107274.32% in Q2 2023.
- The 5-year median for Net Margin is 13879.64% (2021), against an average of 21658.13%.
- Across the five-year window, Net Margin jumped 639879 bps in 2021 and tumbled 9357921 bps in 2023, its largest moves.
- Year by year, Net Margin stood at 2964.62% in 2019, then slumped by 241 bps to 10119.51% in 2020, then retreated by 4 bps to 10531.24% in 2021, then slumped by 67 bps to 17587.81% in 2022, then tumbled by 510 bps to 107274.32% in 2023.
- Per Business Quant, the three latest STME Net Margin figures stand at 107274.32% (Q2 2023), 53225.68% (Q1 2023), and 17587.81% (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 16.74% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.01% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2023 | -107,274.32% |
| Feb 28, 2023 | -53,225.68% |
| Nov 30, 2022 | -17,587.81% |
| Aug 31, 2022 | -29,977.71% |
| May 31, 2022 | -13,695.11% |
| Feb 28, 2022 | -28,314.93% |
| Nov 30, 2021 | -10,531.24% |
| Aug 31, 2021 | -19,995.99% |
| May 31, 2021 | -14,044.09% |
| Feb 28, 2021 | -8,573.18% |
| Nov 30, 2020 | -10,119.51% |
| Aug 31, 2020 | -13,715.20% |
| May 31, 2020 | -330.53% |
| Feb 29, 2020 | -14,971.97% |
| Nov 30, 2019 | -2,964.62% |
| Aug 31, 2019 | -1,208.25% |
| Feb 28, 2017 | -57,300.58% |
| Nov 30, 2016 | -73,593.75% |
| Aug 31, 2016 | -5,077.53% |
| May 31, 2016 | -1,162.48% |